Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy. [electronic resource]
Producer: 20160225Description: 41-7 p. digitalISSN:- 1600-0641
- Adult
- Antiviral Agents -- adverse effects
- DNA, Viral -- analysis
- Drug Carriers
- Drug Therapy, Combination
- Female
- Global Health
- Hepatitis B e Antigens -- immunology
- Hepatitis B virus -- genetics
- Hepatitis B, Chronic -- drug therapy
- Humans
- Incidence
- Interferon-alpha -- adverse effects
- Male
- Peripheral Nervous System Diseases -- diagnosis
- Polyethylene Glycols -- adverse effects
- Recombinant Proteins -- adverse effects
- Telbivudine
- Thymidine -- adverse effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.